| 摘要 |
A process for controlling hyperlipidemia in mammals is disclosed. In this process a hyperlipidemia controlling effective amount of a compound having structural formula: <IMAGE> where R1 is hydrogen, oxo, C1-C6 alkyl or C2-C6 alkanoyl; R2 is hydrogen or oxo; and R3 is hydrogen, C1-C6 alkyl, C2-C6 alkanoyl, C2-C6 carboxyalkyl, phenyl, benzyl or phenyl substituted with C1-C6 alkyl, C2-C6 alkanoyl, C1-C6 alkoxy or halo is applied to mammals. A pharmaceutical composition comprising the above class of compounds having the meanings given herein and a pharmaceutical carrier therefor is also taught.
|
